 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| CDC seeking $400 million to replace lab for deadliest germs The lab investigates deadly and exotic germs like Ebola, smallpox and dangerous new forms of flu. The agency disclosed its plans for a new lab on Friday. The CDC lab is one of only eight U.S. labs with the security and safety features necessary to work with the highest-threat germs, said James Le Duc, ...
| ||||||
| $-0.18 EPS Expected for Bavarian Nordic A/S (BVNRY); NUTRA PHARMA (NPHC) Shorts Down ... It is also developing MVA-BN Filo that is in Phase III trial for the treatment of Ebola and Marburg; MVA-BN RSV, which is in Phase II clinical development stage for the prevention of respiratory syncytial virus; and MVA-BN HPV that is in preclinical development stage to treat human papillomavirus.
| ||||||
| $0.77 EPS Expected for General Mills, Inc. (GIS); Shorts at Nanoviricides New (NYSEAMERICAN ... It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses. Investors sentiment decreased to 1.22 in Q3 2017.
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar